Recruiting Xeroderma Pigmentosum Studies in Baltimore
About Xeroderma Pigmentosum Clinical Trials in Baltimore
Xeroderma pigmentosum is a rare genetic disorder characterized by extreme sensitivity to ultraviolet light, leading to very high risk of skin cancer and eye damage. It is caused by defects in DNA repair mechanisms. Management requires strict UV protection and vigilant cancer surveillance.
There are currently 2 xeroderma pigmentosum clinical trials recruiting participants in Baltimore, MD. These studies are seeking a combined 320 participants. Research is being sponsored by Boehringer Ingelheim, Johns Hopkins University. Clinical trial participation is free and participants receive study-related medical care at no cost.
Xeroderma Pigmentosum Clinical Trials in Baltimore — FAQ
Are there xeroderma pigmentosum clinical trials in Baltimore?
Yes, there are 2 xeroderma pigmentosum clinical trials currently recruiting in Baltimore, MD. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Baltimore?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Baltimore research site will contact you about next steps.
Are clinical trials in Baltimore free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Baltimore studies also compensate for your time and travel.
What xeroderma pigmentosum treatments are being tested?
The 2 active trials in Baltimore are testing new therapies including novel drugs, biologics, and treatment approaches for xeroderma pigmentosum.
Data updated July 20, 2026 from ClinicalTrials.gov